These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 28007364)

  • 1. Factor Eight Inhibitor Bypassing Agent (FEIBA) for Reversal of Target-Specific Oral Anticoagulants in Life-Threatening Intracranial Bleeding.
    Mao G; King L; Young S; Kaplan R
    J Emerg Med; 2017 May; 52(5):731-737. PubMed ID: 28007364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of low and moderate dose FEIBA to reverse major bleeding in patients on direct oral anticoagulants.
    Dager WE; Roberts AJ; Nishijima DK
    Thromb Res; 2019 Jan; 173():71-76. PubMed ID: 30476716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Effectiveness of Factor VIII Inhibitor Bypassing Activity (FEIBA) and Fresh Frozen Plasma in Oral Anticoagulant-Associated Intracranial Hemorrhage: A Retrospective Analysis.
    Yin EB; Tan B; Nguyen T; Salazar M; Putney K; Gupta P; Suarez JI; Bershad EM
    Neurocrit Care; 2017 Aug; 27(1):51-59. PubMed ID: 28243997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor VIII Inhibitor Bypassing Activity (FEIBA) Reversal for Apixaban and Rivaroxaban in Patients With Acute Intracranial and Nonintracranial Hemorrhage.
    Hunt AR; Coffeen SN; Shiltz DL; Ice C; Parker J
    Ann Pharmacother; 2021 Dec; 55(12):1455-1466. PubMed ID: 33843267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhages.
    Pham H; Medford WG; Horst S; Levesque M; Ragoonanan D; Price C; Colbassani H; Piper K; Chastain K
    Am J Emerg Med; 2022 May; 55():38-44. PubMed ID: 35272069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and effectiveness of Factor Eight Inhibitor Bypassing Activity for direct oral anticoagulant-related hemorrhage reversal.
    Engelbart JM; Zepeski A; Galet C; Policeni B; Skeete DA; Faine BA
    Am J Emerg Med; 2019 Feb; 37(2):214-219. PubMed ID: 29802004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world utilization of andexanet alfa.
    Brown CS; Scott RA; Sridharan M; Rabinstein AA
    Am J Emerg Med; 2020 Apr; 38(4):810-814. PubMed ID: 31870672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of FEIBA in Reversing Novel Oral Anticoagulants in Intracerebral Hemorrhage.
    Dibu JR; Weimer JM; Ahrens C; Manno E; Frontera JA
    Neurocrit Care; 2016 Jun; 24(3):413-9. PubMed ID: 26545367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Target-Specific Oral Anticoagulants and Intracranial Bleeding: Management and Outcome in a Single-Center Case Series.
    Senger S; Keiner D; Hendrix P; Oertel J
    World Neurosurg; 2016 Apr; 88():132-139. PubMed ID: 26732970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing bleeding and emergency reversal of newer oral anticoagulants: a review for primary care providers.
    Peacock WF
    Hosp Pract (1995); 2014 Oct; 42(4):75-82. PubMed ID: 25502131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monitoring options and reversal agents for oral anticoagulants].
    Thorup SB; Husted SE; Vang ML
    Ugeskr Laeger; 2014 Apr; 176(9):. PubMed ID: 25096568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of 4-Factor Prothrombin Complex Concentrate as an Antidote for Intracranial Bleeding in Patients Taking Direct Factor Xa Inhibitors.
    Grandhi R; Newman WC; Zhang X; Harrison G; Moran C; Okonkwo DO; Ducruet AF
    World Neurosurg; 2015 Dec; 84(6):1956-61. PubMed ID: 26341438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Risk of Traumatic Intracranial Hematoma Expansion with Factor Xa Inhibitors without Andexanet Reversal.
    Maragkos GA; Nelton EB; Richter S; Stippler M
    World Neurosurg; 2020 Oct; 142():e95-e100. PubMed ID: 32561488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of anticoagulants: an overview of current developments.
    Greinacher A; Thiele T; Selleng K
    Thromb Haemost; 2015 May; 113(5):931-42. PubMed ID: 25832311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Cheng JW; Barillari G
    J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective analysis of the periprocedural management of oral anticoagulants in patients undergoing interventional radiology procedures.
    Marsh K; Ahuja T; Raco V; Green D; Sista AK; Papadopoulos J
    J Thromb Thrombolysis; 2018 Nov; 46(4):451-460. PubMed ID: 30225669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updates in the perioperative and emergency management of non-vitamin K antagonist oral anticoagulants.
    Faraoni D; Levy JH; Albaladejo P; Samama CM;
    Crit Care; 2015 Apr; 19(1):203. PubMed ID: 25925382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Severe Bleeding in Patients Treated With Oral Anticoagulants: Proceedings Monograph From the Emergency Medicine Cardiac Research and Education Group-International Multidisciplinary Severe Bleeding Consensus Panel October 20, 2018.
    Gibler WB; Racadio JM; Hirsch AL; Roat TW
    Crit Pathw Cardiol; 2019 Sep; 18(3):143-166. PubMed ID: 31348075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation.
    Noseworthy PA; Yao X; Abraham NS; Sangaralingham LR; McBane RD; Shah ND
    Chest; 2016 Dec; 150(6):1302-1312. PubMed ID: 27938741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome following intracranial hemorrhage associated with novel oral anticoagulants.
    Kasliwal MK; Panos NG; Munoz LF; Moftakhar R; Lopes DK; Byrne RW
    J Clin Neurosci; 2015 Jan; 22(1):212-5. PubMed ID: 25065949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.